35Pharma

35Pharma is a Canada-based, private, clinical-stage biopharmaceutical company headquartered in Montreal, Quebec, with a research hub in Boston, Massachusetts. It designs and develops next-generation protein-based therapeutics — multi-specific Activin x GDF ligand traps engineered against the TGF-beta superfamily — for pulmonary hypertension, heart failure, cardiometabolic disease and obesity. Its lead program, HS235, is a precision-engineered activin signalling inhibitor that has completed Phase I healthy-volunteer studies and is entering proof-of-principle trials in PAH and PH-HFpEF; a second program, HS370, targets heart failure and obesity. 35Pharma publishes no developer program, API, or machine-readable API artifacts of any kind — it is a therapeutics developer, not a software or data provider. On 25 February 2026 the company announced an agreement to be acquired by GSK plc.

35Pharma is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Biopharmaceutical, and Drug Development.

6.3/100 minimal ▬ flat Agent 0/100 human only Front door AI 1/6 silent Full breakdown ↓
scored 2026-09-25 · rubric v0.23.0
0 APIs
CompanyBiotechnologyPharmaceuticalsBiopharmaceuticalDrug DevelopmentClinical TrialsLife SciencesProtein EngineeringHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-25 · rubric v0.23.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/35pharma: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

35Pharma Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: 35pharma
name: 35Pharma
description: 35Pharma is a Canada-based, private, clinical-stage biopharmaceutical company headquartered in Montreal, Quebec,
  with a research hub in Boston, Massachusetts. It designs and develops next-generation protein-based therapeutics — multi-specific
  Activin x GDF ligand traps engineered against the TGF-beta superfamily — for pulmonary hypertension, heart failure, cardiometabolic
  disease and obesity. Its lead program, HS235, is a precision-engineered activin signalling inhibitor that has completed
  Phase I healthy-volunteer studies and is entering proof-of-principle trials in PAH and PH-HFpEF; a second program, HS370,
  targets heart failure and obesity. 35Pharma publishes no developer program, API, or machine-readable API artifacts of any
  kind — it is a therapeutics developer, not a software or data provider. On 25 February 2026 the company announced an agreement
  to be acquired by GSK plc.
url: https://raw.githubusercontent.com/api-evangelist/35pharma/refs/heads/main/apis.yml
image: https://cdn.prod.website-files.com/679106f289641fbcc75092be/6920bf64870d13ff322aff0b_Open%20graph%20logo.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-parent-company: gsk
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Biopharmaceutical
- Drug Development
- Clinical Trials
- Life Sciences
- Protein Engineering
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.35pharma.com/
- type: PressReleases
  url: https://www.35pharma.com/news
- type: Careers
  url: https://www.35pharma.com/careers
- type: PrivacyPolicy
  url: https://cdn.prod.website-files.com/679106f289641fbcc75092be/690117401d052d425a9a6c62_35Pharma_PrivacyPolicy_EN_FR.pdf
- type: ParentCompany
  url: https://www.gsk.com
- type: DomainSecurity
  url: security/35pharma-domain-security.yml
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 35Pharma is a clinical-stage biopharmaceutical company developing Activin x GDF ligand-trap biologics (lead asset
    HS235); its entire public site is seven marketing pages — technology, pipeline, about, careers, news, publications — with
    no developer section, no API, and no machine-readable artifact on any probed path.
  evidence:
  - url: https://www.35pharma.com/sitemap.xml
    status: 200
  - url: https://www.35pharma.com/openapi.json
    status: 404
  - url: https://www.35pharma.com/llms.txt
    status: 404
  - url: https://www.35pharma.com/.well-known/agent-card.json
    status: 404
  - url: https://www.35pharma.com/apis.json
    status: 404
  checked: '2026-09-05'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/35pharma"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/35pharma/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/35pharma/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.